Search results for “Connective Tissue Disorder” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 260 patents, we discovered top 47 key players by total patent application. Novartis AG, Entropin, Inc., Laboratoires Expanscience SA are dominant in this area. They take 32.69% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 31
Entropin, Inc.
United States
Patent: 30
Laboratoires Expanscience SA
France
Patent: 24
Chong Kun Dang Pharmaceutical Corp.
South Korea
Patent: 20
Milkhaus Laboratory, Inc.
Rhode Island, United States
Patent: 13
HYBRID MEDICAL LLC
United States
Patent: 10
MediWound Ltd.
Israel
Patent: 9
Tobira Therapeutics, Inc.
New Jersey, United States
Patent: 9
Aventis Pharma Deutschland GmbH
Hessen, Germany
Patent: 9
Enceladus Pharmaceuticals BV
Noord-Holland, Netherlands
Patent: 8
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 57 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Chong Kun Dang Pharmaceutical Corp., The Johns Hopkins University, Timber Pharmaceuticals, Inc. take 50.88% of patent filing during this period.
Chong Kun Dang Pharmaceutical Corp.
South Korea
Patent: 17
The Johns Hopkins University
United States
Patent: 8
Timber Pharmaceuticals, Inc.
New Jersey, United States
Patent: 4
Nightingale Health Oyj
Finland
Patent: 3
Tobira Therapeutics, Inc.
New Jersey, United States
Patent: 3
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 2
HYBRID MEDICAL LLC
United States
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Chong Kun Dang Corp
South Korea
Patent: 2
Beijing Aige Stem Cell Technology Co., Ltd
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 57 patents in last 5 years, we discover 5 new entrants. The Johns Hopkins University, Timber Pharmaceuticals, Inc., Nightingale Health Oyj are the most active new entrants in this area.
The Johns Hopkins University
United States
Patent: 8
Timber Pharmaceuticals, Inc.
New Jersey, United States
Patent: 4
Nightingale Health Oyj
Finland
Patent: 3
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 2
Beijing Aige Stem Cell Technology Co., Ltd
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 45 patents, we discovered top 9 universities and scientific research institutions by total patent application. The Johns Hopkins University, The University of North Carolina at Chapel Hill, Colorado State University are dominant in this area. They take 51.11% of the total patent filing.
The Johns Hopkins University
United States
Patent: 8
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 4
Colorado State University
Colorado, United States
Patent: 4
Cornell University
New York, United States
Patent: 3
The University of Newcastle
New South Wales, Australia
Patent: 3
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
University of Bonn
Nordrhein-Westfalen, Germany
Patent: 2
University of East Anglia
NORFOLK, United Kingdom
Patent: 1
Thomas Jefferson University
Pennsylvania, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: